AFP (alpha fetoprotein): Who are you in gastrology?

Cancer Letters

Volumn 357, Issue 1, 2015, Pages 43-46

  Sun, Wenhui ^a   Liu, Yong ^b   Shou, Dawei ^c   Sun, Qiming ^d   Shi, Jianguang ^e   Chen, Li ^c   Liang, Tingbo ^c   Gong, Weihua ^c  

^a Fuyang Women's Hospital   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e NINGBO FIRST HOSPITAL   (China)

Author keywords

AFP; Gastric cancer; Metastasis

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESISTANCE; CLINICAL PRACTICE; DISEASE ACTIVITY; DISTANT METASTASIS; EVIDENCE BASED MEDICINE; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MOLECULAR BIOLOGY; PERSONALIZED MEDICINE; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REFERENCE VALUE; REGULATORY MECHANISM; SHORT SURVEY; STOMACH CANCER; TREATMENT RESPONSE; TUMOR INVASION; BIOSYNTHESIS; METABOLISM; METASTASIS; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

ALPHA-FETOPROTEINS; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84920470000     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.11.018     Document Type: Review

References (39)

1. Bergstrand C.G., Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand. J. Clin. Lab. Invest 1956, 8:174.
2. Ikeda H., Sato Y., Yoneda N., Harada K., Sasaki M., Kitamura S., et al. alpha-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression. Hum. Pathol 2012, 43:1955-1963.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin 2005, 55:74-108.
4. Bourreille J., Metayer P., Sauger F., Matray F., Fondimare A. [Existence of alpha feto protein during gastric-origin secondary cancer of the liver]. Presse Med 1970, 78:1277-1278.
5. Yamamura N., Kishimoto T. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma. Exp. Mol. Pathol 2012, 93:35-39.
6. Kinjo T., Taniguchi H., Kushima R., Sekine S., Oda I., Saka M., et al. Histologic and immunohistochemical analyses of alpha-fetoprotein-producing cancer of the stomach. Am. J. Surg. Pathol 2012, 36:56-65.
7. Lin H.J., Hsieh Y.H., Fang W.L., Huang K.H., Li A.F. Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer. Curr. Oncol 2014, 21:e394-e399.
8. Hirajima S., Komatsu S., Ichikawa D., Kubota T., Okamoto K., Shiozaki A., et al. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J. Gastroenterol 2013, 19:6055-6061.
9. Nakahashi C., Kinoshita T., Konishi M., Nakagohri T., Inoue K., Oda T., et al. Long-term survival achieved by repeated resections of metachronous pulmonary and adrenal metastases of alpha-fetoprotein-producing gastric cancer: report of a case. Surg. Today 2004, 34:784-787.
10. Zhang S., Wang M., Xue Y.H., Chen Y.P. Cerebral metastasis from hepatoid adenocarcinoma of the stomach. World J. Gastroenterol 2007, 13:5787-5793.
11. Tsujikawa T., Tsukamoto H., Itoh A., Andoh A., Sasaki M., Koyama S., et al. Meningitis carcinomatosa originating from an alpha fetoprotein-producing gastric cancer. Intern. Med 2000, 39:223-227.
12. Aoyagi K., Koufuji K., Yano S., Miyagi M., Koga A., Takeda J., et al. Alpha-fetoprotein-producing early gastric cancer: report of two cases. Kurume Med. J. 2003, 50:63-66.
13. Sohda T., Tomioka Y., Inomata S., Morita I., Eguchi K., Aoyagi K., et al. Alpha-fetoprotein (AFP)- and des-gamma-carboxy prothrombin (DCP)-producing adenocarcinoma of the stomach with liver metastasis in a patient with chronic hepatitis C. Intern. Med 2005, 44:294-298.
14. Tahara H., Hirokawa T., Oyama T., Naganuma A., Maruta S., Ban S., et al. Gastric yolk sac tumor complicated with beta-human chorionic gonadotropin-producing metastases. Intern. Med 2008, 47:2145-2149.
15. Takeyama H., Sawai H., Wakasugi T., Takahashi H., Matsuo Y., Ochi N., et al. Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases. World J. Surg. Oncol 2007, 5:79.
16. Terada T. Simultaneous hepatocyte paraffin-1-positive alpha-fetoprotein-producing gastric adenocarcinoma and gastric mucosal-associated lymphoid tissue. Ann. Diagn. Pathol 2012, 16:152-156.
17. Hirasaki S., Tanimizu M., Tsuzuki T., Tsubouchi E., Hidaka S., Hyodo I., et al. Seronegative alpha-fetoprotein-producing early gastric cancer treated with endoscopic mucosal resection and additional surgery. Intern. Med 2004, 43:926-930.
18. Sano M., Inamoto Y., Nagamine D., Yamada H., Ogiwara M., Sekino S., et al. Ovarian and hepatic metastases of gastric carcinoma associated with high serum levels of human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA): a case report. Intern. Med 1992, 31:260-264.
19. Yoshida H., Mamada Y., Taniai N., Mizuguchi Y., Nakamura Y., Nomura T., et al. Ruptured metastatic liver tumor from an alpha-fetoprotein-producing gastric cancer. J. Nippon Med. Sch 2005, 72:236-241.
20. He C.Z., Zhang K.H., Li Q., Liu X.H., Hong Y., Lv N.H. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. BMC Gastroenterol 2013, 13:87.
21. Kumar Dhar D., Kubota H., Tabara H., Kotoh T., Monden N., Igarashi M., et al. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma. Oncology 1999, 56:122-128.
22. Kubota H., Tabara H., Kotoh T., Kumar D.D., Monden N., Watanabe R., et al. Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach. J. Surg. Res 1998, 80:304-308.
23. Ushiku T., Shinozaki A., Shibahara J., Iwasaki Y., Tateishi Y., Funata N., et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am. J. Surg. Pathol 2010, 34:533-540.
24. Kamei S., Kono K., Amemiya H., Takahashi A., Sugai H., Ichihara F., et al. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein. J. Gastroenterol 2003, 38:540-547.
25. Amemiya H., Kono K., Mori Y., Takahashi A., Ichihara F., Iizuka H., et al. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 2000, 59:145-151.
26. Amemiya H., Kono K., Takahashi A., Kamei S., Sugai H., Ichihara F., et al. c-Met expression in a gastric cancer cell line producing alpha-fetoprotein. Surg. Today 2004, 34:115-122.
27. Supriatna Y., Kishimoto T., Furuya M., Tochigi N., Ishiguro H., Tosh D., et al. Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells. Exp. Mol. Pathol 2007, 82:316-321.
28. Kataoka H., Miura Y., Joh T., Seno K., Tada T., Tamaoki T., et al. Alpha-fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene 2001, 20:869-873.
29. Gomez-Martin C., Lopez-Rios F., Aparicio J., Barriuso J., Garcia-Carbonero R., Pazo R., et al. A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond. Cancer Lett 2014, 351:30-40.
30. Sahin I.H., Hassan M.M., Garrett C.R. Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science. Cancer Lett 2014, 345:249-257.
31. Zhang J.F., Shi S.S., Shao Y.F., Zhang H.Z. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach. Chin. Med. J. 2011, 124:1470-1476.
32. Kamata S., Kishimoto T., Kobayashi S., Miyazaki M., Ishikura H. Possible involvement of persistent activity of the mammalian target of rapamycin pathway in the cisplatin resistance of AFP-producing gastric cancer cells. Cancer Biol. Ther 2007, 6:1036-1043.
33. Chang Y.C., Nagasue N., Kohno H., Ohiwa K., Yamanoi A., Nakamura T. Xenotransplantation of alpha-fetoprotein-producing gastric cancers into nude mice. Characteristics and responses to chemotherapy. Cancer 1992, 69:872-877.
34. Dhar D.K., Nagasue N., Yoshimura H., Tachibana M., Tahara H., Matsuura H., et al. Overexpression of P-glycoprotein in untreated AFP-producing gastric carcinoma. J. Surg. Oncol 1995, 60:50-54.
35. Chen J., Rocken C., Treiber G., Jentsch-Ulrich K., Malfertheiner P., Ebert M.P. Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma. Dig. Dis 2003, 21:357-362.
36. Kochi M., Fujii M., Kaiga T., Takahashi T., Morishita Y., Kobayashi M., et al. FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology 2004, 66:445-449.
37. Kripp M., Strobel P., Dinter D., Lukan N., Hochhaus A., Hofheinz R.D. Alpha-fetoprotein expressing metastastic adenocarcinoma of the esophago-gastric junction responding favorably to capecitabine and oxaliplatin. Anticancer Drugs 2009, 20:75-78.
38. Sato Y., Nishimaki T., Date K., Shirai Y., Kurosaki I., Saito Y., et al. Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case. Surg. Today 1999, 29:1075-1078.
39. Gong W., Whitcher G.H., Townamchai N., Xiao X., Ge F. Biomarkers for monitoring therapeutic side effects or various supratherapeutic confounders after kidney transplantation. Transplant. Proc 2012, 44:1265-1269.